Skip to main content
Back
Watch Compare

IO Biotech, Inc.

Data quality: 83%
Also listed as IOBTQ NASDAQ
IOBT
NASDAQ Manufacturing Chemicals
$0.01
▼ $0.04 (-77.08%)
Mkt Cap: 3.45 M
Price
$0.05
Mkt Cap
3.45 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Debt/Equity of 18.29 — high leverage
Negative free cash flow of -81.07 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-7059.45%
Below sector avg (-53.58%)
ROIC-330.00%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
18.29
Above sector avg (0.30)
Current Ratio2.01
Interest CoverageN/A

Valuation

PE (TTM|NTM)
-0.04 | -0.13
Above sector avg (-1.48)
P/B Ratio3.79
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1366 peers)
Metric Stock Sector Median
P/E 0.0 -1.5
P/B 3.8 1.6
ROE % -7059.5 -53.6
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E 18.3 0.3

Analyst Price Target

2 analysts
Hold
Current
$0.01
+19718.2%
Target
$2.18
$0.36
$2.18
$4.00
Forecast
Forward P/E -0.13
Forward EPS -$0.36
Est. Revenue 0.0

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2026 -$0.36
-$0.36 – -$0.36
 0.0 1

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q32025 -$0.12 -$0.25 -108.2%
Q22025 -$0.30 -$0.33 -11.4%
Q12025 -$0.23 -$0.32 -37.6%
Q42024 -$0.38 -$0.46 -18.7%

ETFs Holding This Stock

BRSIX BRSIX
0.08% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -88.35 M
ROE -7059.45% ROA -214.75%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -81.07 M
ROIC -330.00% FCF Growth (3Y) N/A
Safety
Debt / Equity 18.29 Current Ratio 2.01
Interest Coverage N/A Asset Turnover N/A
Working Capital 18.52 M Tangible Book Value 911,000
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.04 Forward P/E -0.13
P/B Ratio 3.79 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -2347.30%
Market Cap 3.45 M Enterprise Value -10.55 M
Per Share
EPS (Diluted TTM) -1.34 Revenue / Share N/A
FCF / Share -1.13 OCF / Share -1.13
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 91.76%
SBC-Adj. FCF -87.40 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021
Revenue — — — —
Net Income -95.49 M -86.08 M -71.46 M -67.88 M
EPS (Diluted) -1.45 -1.98 -2.48 —
Gross Profit — — — —
Operating Income -95.18 M -91.44 M -71.42 M -41.23 M
EBITDA — — — —
R&D Expenses 71.48 M 67.83 M 46.99 M 30.15 M
SG&A Expenses — — — —
D&A 300,000.0 200,000.0 100,000.0 —
Interest Expense — 302,000.0 302,000.0 361,000.0
Income Tax 1.44 M 852,000.0 1.27 M 68,000.0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021
Total Assets 67.70 M 150.72 M 151.81 M 222.29 M
Total Liabilities 20.68 M 17.56 M 12.95 M 10.36 M
Shareholders' Equity 47.02 M 133.16 M 138.85 M 211.92 M
Total Debt 0.0 — — —
Cash & Equivalents 60.03 M 143.19 M 142.59 M 211.53 M
Current Assets 64.95 M 147.26 M 148.22 M 221.74 M
Current Liabilities 19.49 M 15.72 M 10.68 M 10.31 M